Dr. B.S. Tomar's work on Indian childhood cirrhosis Saved many Lives
Dr. Balvir S. Tomar has made a significant contribution to the medical community with his efforts to combat Indian Childhood Cirrhosis, a virus with a 100% fatality rate in young children. Indian Childhood Cirrhosis, is a rare genetic disorder that affects the liver and bile ducts, leading to severe liver damage and scarring. It was a particularly dangerous virus for young children, with a 100% mortality in those under the age of 5.
After returning from abroad, Dr. Tomar established India's first pediatric gastroenterology institute at SMS Medical College in Jaipur to address common childhood diseases such as diarrhea and malnutrition, which were the leading causes of death at the time. This institute was fully funded through public donations and has played a crucial role in addressing these diseases and improving children's health in India.
Dr. B S Tomar is a highly skilled and accomplished medical professional with a wealth of experience in the field of paediatric nutrition as well. He obtained his MD and MBBS degrees from Gajra Raja Medical College and later pursued further studies at Harvard University and Oxford University before specializing in paediatric liver disease at Kings College in London.
Despite the challenges and obstacles faced in finding a cure, Dr. Tomar remained committed to finding a way to combat this deadly virus. Through his hard work and doing lots of research, he found a treatment that ultimately saved countless lives and made a significant impact on the healthcare industry. Today, thanks to the efforts of Dr. Tomar and others, Indian Childhood Cirrhosis is no longer the major threat it once was, and families can receive the care and support they need to navigate and get over this difficult experience.
In addition to his work in the medical field, Dr. Tomar is also highly involved in the education sector. He currently serves as the Chairman of the Niflux group of enterprises, the Chairman of NIMS Hospital, and the Chancellor of NIMS University, all of which are dedicated to providing quality healthcare and education to the public.
Also, during the Covid-19 havoc Dr. B.S. Tomar with his understanding of the severity of the virus and what impact it had on people, he converted the NIMS Hospital into a quarantine centre. Leading to this, people who were infected with the virus had a place to get their treatments and nourishment done. During this time, he did research on ashwagandha commonly known as Indian Winter cherry or Indian Ginseng, ginger, black pepper, basil leaves, and honey. Prof. (Dr.) Balvir S. Tomar found out that these herbs are able to increase the immunity of patients and realized that where the patients were getting corona-negative in 10 to 12 days, now they were recovering in 5-7 days with improved immunity.
Dr. Tomar is a firm believer in the importance of helping others and has always encouraged others to be kind and compassionate toward those in need. He attributes his success to his values and principles and is committed to using his medical expertise to benefit society.
He has also decided to use his skills and resources to address social issues and create positive change in India. He has chosen to become a social entrepreneur, which means he is using his clinical acumen and enthusiasm to tackle problems related to health and make India a healthier place. One of Dr. Tomar's main goals as a social entrepreneur is to serve the masses of India, particularly those who are most marginalized and disadvantaged. This involves working with communities to provide access to education, healthcare, and other basic necessities.
Born on 28 August, 1950 in a poor, yet noble family in Varanasi, Dr. Tomar always had ambitions to serve society in different ways. He is an exceptional individual who has dedicated his life to positively impacting the world. His legacy in the world will be felt for centuries to come as a result of his work as a social entrepreneur and philanthropist, which has enhanced the quality of life for countless people and still does.